Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperphosphatemia in children receiving peritoneal dialysis--an educational program.

Richard T Blaszak1, Mark M Mitsnefes, Mohammad Ilyas

  • 1Division of Nephrology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, 800 Marshall Street, Little Rock, AR 72202-3591, USA. blaszakrichardt@uams.edu

Pediatric Nephrology (Berlin, Germany)
|May 6, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of gut microbiome motif associated with active tuberculosis - A case control study.

Bioinformation·2026
Same author

Bile acid metabolites and carotid intima media thickness in the Chronic Kidney Disease in Children (CKiD) study.

Pediatric nephrology (Berlin, Germany)·2026
Same author

ML-FSID-FIS: A Multi-Level Feature Selection and Fuzzy Inference System for Intrusion Detection in IoMT.

Sensors (Basel, Switzerland)·2026
Same author

Generation of biologically responsive colon-like intestinal tissue patches from human induced pluripotent stem cells using a rapid co-differentiation platform.

Stem cell research & therapy·2026
Same author

Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease.

JAMA pediatrics·2026
Same author

FedSMOTE-DP: Privacy-Aware Federated Ensemble Learning for Intrusion Detection in IoMT Networks.

Sensors (Basel, Switzerland)·2026

A 3-month patient education program did not significantly improve serum phosphorus, calcium, or parathyroid hormone (PTH) levels in patients with hyperphosphatemia. Knowledge of dietary phosphorus and phosphate binders also showed no improvement.

Area of Science:

  • Nephrology
  • Endocrinology
  • Public Health

Background:

  • Hyperphosphatemia is linked to severe health issues, including secondary hyperparathyroidism, renal osteodystrophy, and cardiovascular calcification.
  • Effective management of hyperphosphatemia is crucial for improving patient outcomes and reducing mortality risk.

Purpose of the Study:

  • To assess the impact of a 3-month educational intervention on serum phosphorus, calcium, parathyroid hormone (PTH), and patient knowledge.
  • To determine if enhanced patient understanding of dietary phosphorus and phosphate binder management can improve clinical markers.

Main Methods:

  • A one-group, pretest-posttest study design was employed.
  • Evaluated serum phosphorus, calcium, calcium-phosphorus product, and PTH levels at pretreatment, during treatment, and posttreatment.

Related Experiment Videos

  • Assessed patient knowledge through testing before and after the educational intervention.

    • Main Results:

    • No significant changes were observed in mean serum phosphorus, calcium, calcium-phosphorus product, or PTH levels throughout the study.
    • Patient test scores regarding dietary phosphorus and phosphate binder management remained unchanged.
    • Despite the educational program, key biochemical markers frequently remained outside K/DOQI target guidelines.

    Conclusions:

    • A 3-month patient education program focusing on dietary phosphorus, phosphate binders, and compliance had no significant effect on biochemical parameters or patient knowledge.
    • Current educational strategies may be insufficient to alter patient behavior and improve management of hyperphosphatemia.
    • Further research is needed to identify more effective interventions for managing hyperphosphatemia and its associated complications.